Letko, Brosseau & Associates’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.19M	Hold	32,825	–	–	0.07%	68
2025 Q4	$3.7M	Sell	32,825 -2,500	-7%	-$287K	0.06%	68
2025 Q3	$3.54M	Sell	35,325 -3,000	-8%	-$270K	0.06%	68
2025 Q2	$3.18M	Sell	38,325 -1,675	-4%	-$134K	0.06%	68
2025 Q1	$3.24M	Sell	40,000 -2,950	-7%	-$264K	0.07%	67
2024 Q4	$3.87M	Sell	42,950 -5,000	-10%	-$484K	0.07%	70
2024 Q3	$4.74M	Sell	47,950 -8,950	-16%	-$879K	0.09%	72
2024 Q2	$5.28M	Sell	56,900 -8,900	-14%	-$798K	0.1%	74
2024 Q1	$6.24M	Hold	65,800	–	–	0.11%	74
2023 Q4	$5.88M	Hold	65,800	–	–	0.11%	72
2023 Q3	$4.8M	Sell	65,800 -4,500	-6%	-$359K	0.09%	73
2023 Q2	$5.85M	Sell	70,300 -7,200	-9%	-$602K	0.11%	72
2023 Q1	$5.91M	Sell	77,500 -500	-0.6%	-$41.5K	0.11%	74
2022 Q4	$6.47M	Buy	+78,000	New	+$6.31M	0.12%	79